Acetylcholinesterase Inhibition Promotes Retinal Vasoprotection and Increases Ocular Blood Flow in Experimental Glaucoma-Reference-Cited by-同舟云学术

Acetylcholinesterase Inhibition Promotes Retinal Vasoprotection and Increases Ocular Blood Flow in Experimental Glaucoma

Published:2013-05-03 Issue:5 Volume:54 Page:3171
ISSN:1552-5783
Container-title:Investigative Opthalmology & Visual Science
language:en
Short-container-title:Invest. Ophthalmol. Vis. Sci.

Author:

Almasieh Mohammadali¹,MacIntyre Jessica N.²,Pouliot Mylène³,Casanova Christian³,Vaucher Elvire³,Kelly Melanie E. M.²,Di Polo Adriana¹

Affiliation:

1. Department of Pathology and Cell Biology and Groupe de Recherche sur le Système Nerveux Central (GRSNC), University of Montreal, Montreal, Quebec, Canada

2. Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada

3. School of Optometry, University of Montreal, Montreal, Quebec, Canada

Publisher

Association for Research in Vision and Ophthalmology (ARVO)

Subject

General Medicine

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in Cholinesterase Inhibitor Research—An Overview of Preclinical Studies of Selected Organoruthenium(II) Complexes;International Journal of Molecular Sciences;2024-08-21

2. Improved MRI methods to quantify retinal and choroidal blood flow applied to a model of glaucoma;Frontiers in Ophthalmology;2024-05-13

3. Efficient and knowledge-based hierarchal virtual screening applied to identify potential inhibitors of cholinesterase enzyme;Chemical Papers;2024-04-08

4. Alzheimer's disease current therapies, novel drug delivery systems and future directions for better disease management;Journal of Controlled Release;2024-03

5. Alzheimer Disease Treatment With Acetylcholinesterase Inhibitors and Incident Age-Related Macular Degeneration;JAMA Ophthalmology;2024-02-01